by The global breast cancer market size was approximate at US$ 31.89 billion in 2022 and is anticipated to grow US$ 70.51 billion by 2030, registering a compound annual growth rate of 10.43% from 2022 to 2030.
The breast cancer market report covering various industry elements and growth trends helpful for predicting the market’s future.
The study provides a strong base for the breast cancer market to be segmented into different segments. In fact, the study also covers the maximum market share during the assessment period by 2030.
This study is based on the partners that are highly competitive, key players as well as their market revenue in the forecast years of 2022 to 2030. There is also a strong focus on product revenues, sales, product categories and even the products that are experiencing the most traction. In this manner, the breast cancer report also speaks about the effectiveness of this market along with its growth during the forecast period of 2030. Other major attributes of the breast cancer market have been studied and analysed across many developments.
Request a Sample Copy of This Report @ https://www.precedenceresearch.com/sample/2396
Breast Cancer Market Report Scope
| Report Coverage | Details |
| Market Size in 2022 | USD 31.89 Billion |
| Market Size by 2030 | USD 70.51 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 10.43% |
| Largest Market | North America |
| Second Largest Market | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered |
|
Also read: Chemistry 4.0 Market Growth Prospects, Forast up to 2030ec
Research Approach
The comprehensive report on the global breast cancer market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products. Following this, the report provides detailed explanation of objectives of this study and laid down by accredited agencies in the purview of research in the global breast cancer market.
It is followed by market introduction, market dynamics, and an overview of the global market, which includes analysis of market drivers, restraints, and trends pertaining to the global market. Furthermore, Y-o-Y growth analysis with elaborated insights has been provided in order to understand the Y-o-Y growth trend of the global market.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
Key Players
- Merck & Co
- Bristol Myers Squiib
- Kyowa Kirin
- Eisai Co.Ltd
- Sanofi
- Pfizer Inc
- AstraZeneca
- Novartis AG
- Eli Lilly and Company
- Genentech
- Mylan Laboratories
- Celltrion
- Fresenius Kabi
- Baxter Healthcare Corporation
- Halozyme Inc
- GlaxoSmithKline
Breast Cancer Market Segmentations
By Therapy
- Targeted Therapy
- Abemaciclib
- Adotrastuzumab Emtansine
- Everolimus
- Trastuzumab
- Ribociclib
- Palbocicib
- Pertuzumab
- Olaparib
- Others
- Hormonal Therapy
- Selective Estrogen Receptor Modulators
- Aromatase Inhibitors
- Estrogen Receptor Downregulators
- Chemotherapy ( Epothiones, Taxanes, Alkylating agents, Anthracyclines, Anti-metabolites)
- Immunotherapy
- Surgery and radiation therapy
- Biologic therapy
By Cancer Type
- Hormone Receptor
- HER2+
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa (MEA)
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Breast Cancer Market
5.1. COVID-19 Landscape: Breast Cancer Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Breast Cancer Market, By Therapy
8.1. Breast Cancer Market, by Therapy, 2022-2030
8.1.1 Targeted Therapy
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Hormonal Therapy
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Surgery and radiation therapy
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Biologic therapy
8.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Breast Cancer Market, By Cancer Type
9.1. Breast Cancer Market, by Cancer Type, 2022-2030
9.1.1. Hormone Receptor
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. HER2+
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Breast Cancer Market, By Distribution Channel
10.1. Breast Cancer Market, by Distribution Channel, 2022-2030
10.1.1. Hospital Pharmacies
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Retail Pharmacies
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Online Pharmacies
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Breast Cancer Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Therapy (2017-2030)
11.1.2. Market Revenue and Forecast, by Cancer Type (2017-2030)
11.1.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Therapy (2017-2030)
11.1.4.2. Market Revenue and Forecast, by Cancer Type (2017-2030)
11.1.4.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Therapy (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Cancer Type (2017-2030)
11.1.5.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Therapy (2017-2030)
11.2.2. Market Revenue and Forecast, by Cancer Type (2017-2030)
11.2.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Therapy (2017-2030)
11.2.4.2. Market Revenue and Forecast, by Cancer Type (2017-2030)
11.2.4.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Therapy (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Cancer Type (2017-2030)
11.2.5.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Therapy (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Cancer Type (2017-2030)
11.2.6.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Therapy (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Cancer Type (2017-2030)
11.2.7.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Therapy (2017-2030)
11.3.2. Market Revenue and Forecast, by Cancer Type (2017-2030)
11.3.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Therapy (2017-2030)
11.3.4.2. Market Revenue and Forecast, by Cancer Type (2017-2030)
11.3.4.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Therapy (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Cancer Type (2017-2030)
11.3.5.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Therapy (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Cancer Type (2017-2030)
11.3.6.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Therapy (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Cancer Type (2017-2030)
11.3.7.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Therapy (2017-2030)
11.4.2. Market Revenue and Forecast, by Cancer Type (2017-2030)
11.4.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Therapy (2017-2030)
11.4.4.2. Market Revenue and Forecast, by Cancer Type (2017-2030)
11.4.4.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Therapy (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Cancer Type (2017-2030)
11.4.5.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Therapy (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Cancer Type (2017-2030)
11.4.6.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Therapy (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Cancer Type (2017-2030)
11.4.7.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Therapy (2017-2030)
11.5.2. Market Revenue and Forecast, by Cancer Type (2017-2030)
11.5.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Therapy (2017-2030)
11.5.4.2. Market Revenue and Forecast, by Cancer Type (2017-2030)
11.5.4.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Therapy (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Cancer Type (2017-2030)
11.5.5.3. Market Revenue and Forecast, by Distribution Channel (2017-2030)
Chapter 12. Company Profiles
12.1. Merck & Co
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Bristol Myers Squiib
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Kyowa Kirin
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Eisai Co.Ltd
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Sanofi
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Pfizer Inc
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. AstraZeneca
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Novartis AG
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Eli Lilly and Company
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Genentech
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Why should you invest in this report?
If you are aiming to enter the global breast cancer market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for breast cancer are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
